Andrew Hall
Chief Executive Officer en IMV INC. .
Fortuna: 12 $ al 31/12/2023
Perfil
Andrew Hall is currently the Chief Executive Officer & Director at IMV, Inc. He previously worked as an Executive Director of Business Development at Celgene Corp.
and as an Executive Director of Global Women's Health at Merck & Co., Inc. Mr. Hall completed his undergraduate degree at the University of Melbourne and his graduate degree at RMIT University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMV INC.
0.05% | 20/03/2023 | 6 100 ( 0.05% ) | 12 $ | 31/12/2023 |
Cargos activos de Andrew Hall
| Empresas | Cargo | Inicio |
|---|---|---|
| IMV INC. | Chief Executive Officer | 04/08/2021 |
Antiguos cargos conocidos de Andrew Hall.
| Empresas | Cargo | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| CELGENE | Corporate Officer/Principal | - |
Formación de Andrew Hall.
| University of Melbourne | Undergraduate Degree |
| RMIT University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| IMV INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Hall
